Edmund Lee

Company: Regulus Therapeutics

Job title: Vice President - Translational Medicine

Seminars:

Targeting MicroRNAs in CKD: Leveraging RNA Biology for Precision Therapeutics in Kidney Disease 2:00 pm

Explore how Regulus Therapeutics’ antisense oligonucleotide platform targets microRNAs to regulate gene expression in CKD pathways like fibrosis and inflammation, aiming to limit off-target effects and directly impact cellular mechanisms Discuss advancements in selective kidney targeting, where oligonucleotides preferentially bind to microRNAs in renal cells, achieving localized therapeutic action and minimizing systemic effects Review preclinical…Read more

day: Day Two PM